Jefferson E. Davis
2021
In 2021, Jefferson E. Davis earned a total compensation of $634.8K as Chief Business Officer at Opexa Therapeutics.
Compensation breakdown
| Option Awards | $308,130 |
|---|---|
| Salary | $326,667 |
| Total | $634,797 |
Davis received $326.7K in salary, accounting for 51% of the total pay in 2021.
Davis also received $308.1K in option awards.
Rankings
In 2021, Jefferson E. Davis' compensation ranked 10,163rd out of 12,405 executives tracked by ExecPay. In other words, Davis earned more than 18.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,163 out of 12,405 | 18th |
Division Manufacturing | 4,492 out of 5,494 | 18th |
Major group Chemicals And Allied Products | 2,004 out of 2,369 | 15th |
Industry group Drugs | 1,777 out of 2,090 | 15th |
Industry Pharmaceutical Preparations | 1,321 out of 1,537 | 14th |
Source: SEC filing on April 15, 2022.
Davis' colleagues
We found two more compensation records of executives who worked with Jefferson E. Davis at Opexa Therapeutics in 2021.